Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
About this item
Full title
Author / Creator
Arabi, Yaseen M. , Hajeer, Ali H. , Luke, Thomas , Raviprakash, Kanakatte , Balkhy, Hanan , Johani, Sameera , Al-Dawood, Abdulaziz , Al-Qahtani, Saad , Al-Omari, Awad , Al-Hameed, Fahad , Hayden, Frederick G. , Fowler, Robert , Bouchama, Abderrezak , Shindo, Nahoko , Al-Khairy, Khalid , Carson, Gail , Taha, Yusri , Sadat, Musharaf and Alahmadi, Mashail
Publisher
United States: U.S. National Center for Infectious Diseases
Journal title
Language
English
Formats
Publication information
Publisher
United States: U.S. National Center for Infectious Diseases
Subjects
More information
Scope and Contents
Contents
We explored the feasibility of collecting convalescent plasma for passive immunotherapy of Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using ELISA to screen serum samples from 443 potential plasma donors: 196 patients with suspected or laboratory-confirmed MERS-CoV infection, 230 healthcare workers, and 17 household contact...
Alternative Titles
Full title
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
Authors, Artists and Contributors
Author / Creator
Hajeer, Ali H.
Luke, Thomas
Raviprakash, Kanakatte
Balkhy, Hanan
Johani, Sameera
Al-Dawood, Abdulaziz
Al-Qahtani, Saad
Al-Omari, Awad
Al-Hameed, Fahad
Hayden, Frederick G.
Fowler, Robert
Bouchama, Abderrezak
Shindo, Nahoko
Al-Khairy, Khalid
Carson, Gail
Taha, Yusri
Sadat, Musharaf
Alahmadi, Mashail
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0076600a86934e87bb4ea668abdd2e4d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0076600a86934e87bb4ea668abdd2e4d
Other Identifiers
ISSN
1080-6040
E-ISSN
1080-6059
DOI
10.3201/eid2209.151164
